Literature DB >> 28402922

Toxicity of triptolide and the molecular mechanisms involved.

Chen Xi1, Shaojun Peng2, Zhengping Wu2, Qingping Zhou3, Jie Zhou4.   

Abstract

Triptolide (TP), a major active and toxic ingredient isolated from the traditional Chinese herb Tripterygium wilfordii Hook f. (TWHF). A widespread application of TP raises the question on the safety of its use in clinical settings. The metabolism of TP is mediated by hepatic cytochrome P450s, and a strong correlation exists between TP toxicity and CPY3A. Toxicity of TP and the molecular mechanisms of its toxic effects have been studied in recent years. Studies have demonstrated that TP exposure results in injury of various organs, including the liver, kidney, testes, ovary, and heart in animals and even in humans, according to clinical case reports. Moreover, on the cellular level, TP has been reported to be associated with diverse toxic effects, encompassing membrane damage, mitochondrial disruption, metabolism dysfunction, endoplasmic reticulum stress, oxidative stress, apoptosis and autophagy. This review presents an overview of the current findings related to TP toxicity with an emphasis on biological targets and the molecular mechanisms that may be involved, thus providing a systematic understanding of the mechanisms by which TP affects cells and tissues in vitro and in vivo.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Molecular mechanisms; Protection; Toxicity; Toxicokinetics; Triptolide

Mesh:

Substances:

Year:  2017        PMID: 28402922     DOI: 10.1016/j.biopha.2017.04.003

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  54 in total

1.  Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide.

Authors:  Xin-Jun Cai; Wei-Dong Fei; Ying-Ying Xu; Hong Xu; Gao-Yi Yang; Jia-Wei Cao; Jian-Jun Ni; Zeng Wang
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

2.  Proteomic Study on the Reproductive Toxicity of Tripterygium Glycosides in Rats.

Authors:  Yanlin Dai; Lihui Sun; Shanshan Han; Shanshan Xu; Long Wang; Ying Ding
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

3.  Triptolide potentiates the cytoskeleton-stabilizing activity of cyclosporine A in glomerular podocytes via a GSK3β dependent mechanism.

Authors:  Xianhui Liang; Bohan Chen; Pei Wang; Yan Ge; Deepak K Malhotra; Lance D Dworkin; Zhangsuo Liu; Rujun Gong
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

4.  Triptolide inhibits TGF-β-induced matrix contraction and fibronectin production mediated by human Tenon fibroblasts.

Authors:  Yang Liu; Ping-Ping Liu; Lei Liu; Xiao-Shuo Zheng; Hui Zheng; Cheng-Cheng Yang; Ci-Ren Luobu; Ye Liu
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

5.  Antitumor properties of triptolide: phenotype regulation of macrophage differentiation.

Authors:  Han Li; Liping Li; Huifang Mei; Guofeng Pan; Xinzhi Wang; Xin Huang; Tao Wang; Zhenzhou Jiang; Luyong Zhang; Lixin Sun
Journal:  Cancer Biol Ther       Date:  2019-10-30       Impact factor: 4.742

6.  Triptolide protects against white matter injury induced by chronic cerebral hypoperfusion in mice.

Authors:  Yu-Shan Wan; Yi You; Qian-Yun Ding; Yi-Xin Xu; Han Chen; Rong-Rong Wang; Yu-Wen Huang; Zhong Chen; Wei-Wei Hu; Lei Jiang
Journal:  Acta Pharmacol Sin       Date:  2021-04-06       Impact factor: 6.150

7.  Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling.

Authors:  Size Li; Yiqun Yu; Xiaolan Bian; Li Yao; Min Li; Yan-Ru Lou; Jing Yuan; Hai-Shu Lin; Lucy Liu; Bing Han; Xiaoqiang Xiang
Journal:  Arch Toxicol       Date:  2021-03-13       Impact factor: 5.153

8.  Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma.

Authors:  Kevin Liaw; Rishi Sharma; Anjali Sharma; Sebastian Salazar; Santiago Appiani La Rosa; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2020-12-05       Impact factor: 9.776

9.  Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

10.  Triptolide inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cells through the inhibition of NF-κB and AP-1 signaling pathways.

Authors:  On-Yu Hong; Hye-Yeon Jang; Kwang-Hyun Park; Young-Ju Jeong; Jong-Suk Kim; Hee Suk Chae
Journal:  Oncol Lett       Date:  2021-05-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.